Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Salud Publica De Mexico|December 8, 2009
[Genomic basis for breast cancer: advances in personalized medicine]Alfredo Hidalgo-Miranda, Gerardo Jiménez-SánchezBoletin Medico Del Hospital Infantil De Mexico|January 25, 2018
[Acute lymphoblastic leukemia: a genomic perspective]Silvia Jiménez-Morales, Alfredo Hidalgo-Miranda, Julián Ramírez-BelloFrontiers in Oncology|August 16, 2024
Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkersSugela Susana Blancas-Zugarazo, Elizabeth Langley, Alfredo Hidalgo-MirandaFrontiers in Immunology|June 21, 2023
The current advances of lncRNAs in breast cancer immunobiology researchMarco Antonio Fonseca-Montaño, Karla Itzel Vázquez-Santillán, Alfredo Hidalgo-MirandaFrontiers in Genetics|June 1, 2023
LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancerMarco Antonio Fonseca-Montaño, Mireya Cisneros-Villanueva, Isabelle Coales, et al.International Journal of Oncology|July 18, 2018
Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review)Silvia Jiménez-Morales, Carlos J Pérez-Amado, Elizabeth Langley, et al.Cancer Biology & Therapy|December 9, 2014
miRNA biogenesis: biological impact in the development of cancerSandra L Romero-Cordoba, Ivan Salido-Guadarrama, Mauricio Rodriguez-Dorantes, et al.Archives of Medical Research|December 2, 2022
Cancer GenomicsMarco A Fonseca-Montaño, Susana Blancas, Luis A Herrera-Montalvo, et al.International Journal of Molecular Sciences|July 24, 2021
Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer ProgressionCarlos Jhovani Pérez-Amado, Amellalli Bazan-Cordoba, Alfredo Hidalgo-Miranda, et al.Frontiers in Physiology|August 24, 2016
Insights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismFredy O Beltrán-Anaya, Alberto Cedro-Tanda, Alfredo Hidalgo-Miranda, et al.Pageof 11